Attached files

file filename
10-K - TIENS BIOTECH GROUP USA INCv216077_10k.htm
EX-21.1 - TIENS BIOTECH GROUP USA INCv216077_ex21-1.htm
EX-31.1 - TIENS BIOTECH GROUP USA INCv216077_ex31-1.htm
EX-10.48 - TIENS BIOTECH GROUP USA INCv216077_ex10-48.htm
EX-10.49 - TIENS BIOTECH GROUP USA INCv216077_ex10-49.htm
EX-10.46 - TIENS BIOTECH GROUP USA INCv216077_ex10-46.htm
EX-10.51 - TIENS BIOTECH GROUP USA INCv216077_ex10-51.htm
EX-10.47 - TIENS BIOTECH GROUP USA INCv216077_ex10-47.htm
EX-10.50 - TIENS BIOTECH GROUP USA INCv216077_ex10-50.htm
 
Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND ACTING CHIEF FINANCIAL
 OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Tiens Biotech Group (USA), Inc. (the “Registrant”) on Form 10-K for the fiscal year ended December 31, 2010 as filed with the Securities and Exchange Commission (the “Report”), each of the undersigned, Jinyuan Li, Chief Executive Officer, Acting Chief Financial Officer, President and Chairman of the Registrant, certifies, pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:

 
1. 
The Report fully complies, in all material respects, with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
2. 
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant as of and for the period covered by the Report.

Pursuant to the rules and regulations of the Securities and Exchange Commission, this certification is being furnished and is not deemed filed.
 
 Date: March 31, 2011
 
/s/ Jinyuan Li
   
Jinyuan Li
   
Chief Executive Officer, Acting Chief Financial Officer
and President
   
(Principal Executive Officer, Principal Financial and
Accounting Officer)